Tag Archives: Cannabinoid

The 'Limitless Future' of a Weed Extract that Doesn't Get You High

The ‘Limitless Future’ of a Weed Extract That Doesn’t Get You High

The ‘Limitless Future’ of a Weed Extract That Doesn’t Get You High

CBD—a purified weed extract that won’t get you stoned—is used to treat everything from breast cancer to stress relief, epilepsy to aching joints. VICE met up with David Bonvillain, who runs the CBD company Elite Botanicals, for an inside scoop on the extract’s “limitless future.”

Arkansas Company

Dewmar International BMC, Inc. (DEWM) Files Provisional Patent to Treat Lung Cancer with Cannabinoids

BATON ROUGE,La., July 18, 2017 /Weed Wire/ — Dewmar International BMC, Inc. (OTC PINK: DEWM) announced today that it has filed a provisional patent with the United States Patent and Trademark Office for the treatment of lung cancer with cannabinoids.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

This New Study Should Encourage Marijuana Stock Investors

This New Study Should Encourage Marijuana Stock Investors

The marijuana industry, and marijuana stock investors for that matter, have been expanding by leaps and bounds over the past two decades. One good way to keep this up is through university-based clinical studies. Studies like these really fan the flame of what might be possible with cannabis-based medicines.

Alternate Health Corp - zika

Alternate Health Announces Completion of Initial Study to Treat Zika Virus Symptoms with Hemp-Derived Cannabinoids

TORONTO, Ontario, May 16, 2017 /Weed Wire/ — Alternate Health Corp. (CSE:AHG, OTC:AHGIF), a diverse healthcare company revolutionizing patient care and research in the emerging medical cannabis industry, announced today the completion of its initial study to demonstrate the effectiveness of cannabinoids in treating chronic post-Zika virus symptoms.

These 5 Marijuana Stocks Lost a Combined $193 Million in 2016

These 5 Marijuana Stocks Lost a Combined $193 Million in 2016

These 5 marijuana stocks lost a combined $193 Million in 2016. Though they’re some of the top performers, they’re also among the companies losing the most money on an annual basis.

5 Drug-Developing Marijuana Stocks You Need to Know

5 Drug-Developing Marijuana Stocks You Need to Know

Medical marijuana remains the safest investment route — if you’re forced to choose one — so here’s a brief rundown of the cannabinoid-based drugs working their way through clinical and preclinical trials.

: 3 Marijuana Stocks to Buy if You're Leery of Buying Marijuana Stocks

3 Stocks to Buy if You’re Leery of Buying Marijuana Stocks

Although marijuana stocks have skyrocketed in the last couple of years, many investors have been understandably leery of jumping on board. Check out why investors might like these three stocks that don’t fit the mold of most marijuana stocks.

How to Profit from the U.S.-U.K. Marijuana “Research Gap”

How to Profit From the U.S. and U.K. Marijuana ‘Research Gap’

Legal marijuana flat-Earthers, like U.S. Attorney General Jeff Sessions, have tried many methods to discredit breakthroughs in medical cannabis, but these efforts at discrediting cannabis stop at the U.S. border.

Impact Network

IMPACT Network Announces Clinical Research Focus on Cannabis for Women

DENVER, March 15, 2017 /Weed Wire/ — IMPACT Network, a nonprofit dedicated to Improving Marijuana Policy and Accelerating Cannabinoid Therapeutics, announced their new focus on cannabis for women’s health, as well as several new executive team appointments that will support Founder and Executive Director, Dr. Michele Ross, and newly promoted Deputy Executive Director Susan Parker.

Post-Traumatic Stress and National TV Spot

Federal Overreach: Round 1 Hoban Law Group Files Ninth Circuit Petition to Challenge Recent DEA Classification of “Marihuana Extracts”

DENVER, Jan. 16, 2016 /Weed Wire/ — Hoban Law Group has filed a petition in San Francisco’s United States Court of Appeals for the Ninth Circuit to challenge what appears to be the DEA’s attempt to control an otherwise lawful substance.

Vitality Biopharma: A Seriously Undervalued Cannabis Stock

Vitality Biopharma: A Seriously Undervalued Cannabis Stock

While many investors were drawn in by the myth that millions would be made by investing in the companies that purportedly planned to cultivate and sell medical and leisure based marijuana, they should have been focused on investing in companies that are intent on utilizing the plant’s cannabinoid properties, which are consistently demonstrating extraordinary benefit in treating a host of medical conditions.

icclogo

International Cannabis Corporation Announces Incorporation of Additional Land to Increase Production Capacity

VANCOUVER, British Columbia, Dec. 20, 2016 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) has entered into an agreement to lease approximately 9 hectares of additional land adjacent to the Company’s existing property used for the production of cannabinoid extracts and by-products for medicinal use and industrial hemp.

Journey into the Endocannabinoid System

Journey into the Endocannabinoid System

From children with seizures to athletes with joint pain, people are using cannabis to cope effectively. This one herb and its variety of therapeutic compounds seem to affect every aspect of our bodies and minds. How is this possible?

Dixie Brands: Dixie Elixirs and Edibles

Dixie Brands, Inc. Launches Aceso Daily Powder, the First-Ever Cannabinoid Drink Mix

DENVER, May 11, 2016 /Weed Wire/ — Dixie Brands Inc. (Dixie), a leader in emerging cannabinoid extraction and wellness platforms, announces the expansion of its Aceso line of products with the launch of a delicious, dissolvable effervescent drink mix featuring hemp-derived cannabinoids, boosted with all-natural vitamins and terpenes.

ACS to Measure Edibles

New Technique Could More Accurately Measure Cannabinoid Dosage in Marijuana Munchies

SAN DIEGO, March 15, 2016 /Weed Wire/ — As more states decriminalize recreational use of marijuana and expand its medical applications, concern is growing about inconsistent and inaccurate dosage information listed on many products, including brownies and other edibles.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Targets Successful Autism Treatments and Brings Family Autism Advocate Mieko Hester-Perez on Its Scientific Advisory Board

COLORADO SPRINGS, Colo., Feb. 8, 2016/ Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced its next critical ailment target is autism and brings Mieko Hester-Perez on its Scientific Advisory Board to lead this charge.

Revolution Enterprises

Revolution Cannabis Analytics Launches First-of-its-Kind Statewide Study

DOWNERS GROVE, Ill., Dec. 7, 2015 /WeedWire/ — Revolution Cannabis Analytics will document the choices, attitudes, and experience of medical cannabis patients in Illinois in a first-of-its-kind study.

Zynerba

Zynerba: The Need for Speculative Fortitude

Zynerba presented the status of its research program at BIO Investor Forum. This is a 14-year-old annual biotech gathering, with roughly 600 attendees from 21 countries, and the presentation, in San Francisco, looked likely to be a big event in this company’s development.

Lexaria Releases Press Kit to the Media

KELOWNA, B.C., July 7, 2015 /Weed Wire/ – Lexaria Corp. (CSE: LXX) (OTCQB: LXRP), a food sciences company focused on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its proprietary infusion technology, today announced the release of its official press kit providing media partners with detailed information about the company and its technologies, as well as high resolution images and other assets to assist with content creation.

Cannasafe Analytics

CannaSafe Analytics (CSA LABS) is the only national ISO17025:2005 accredited cannabis testing laboratory. CannaSafe’s accredited scope includes full cannabinoid and terpenoid profiling, microbiological, heavy metals, pesticide contamination, plant growth regulars and residual solvents.


Top